Yield Pharma, located in Suzhou, China, is a biochemistry company providing intermediates, APIs and electron compounds. As a research driven and custom-orientated company, Yield pharma offers global pharmaceutical and electronic manufactors a broad and integrated services of laboratory research and mass manufacturing. Yield pharma has a competitive team of scientific research, professional apparatus and an advanced management system. With the help of these, Yield successfully developed the synthesizing processes in industrial production of EDOT, -dimethylsulfamide, 4, 6-Dichloro-5-(2-methoxyphenoxy)[2, 2']bipyrimidinyl, Cyclopropane sulfonamide and Cyclopropanesulfonyl chloride, among which, EDOT and -dimethylsulfamide are ISO 9001 certified, and also developed the pilot process of some pharmaceutical intermediates and APIs, such as 2, 5-dichloropyrimidine and quinoline boronic acid, etc. Besides, Yield has applied the patent of synthesis process of EDOTï¼?CN101220038ï¼?, 2-chloro-5-aminopyrimidineï¼?CN101219997ï¼?and 4, 6-Dichloro-5-(2-methoxyphenoxy)[2, 2']bipyrimidinylï¼?CN101279984ï¼?. The head quarter of Yield lies in Suzhou Industrial Park. Its R&D center, located in Nanjing Yuhua Economic Development Zone, covers 1000 square meters. The pilot-plant of Yield is in Shipai Town of Kunshan with an area of 31122.6 square meters. There is also a manufacturing factory in located in Jiangsu Yancheng Binhai Economic Development Zone with an area of 35 acres. R&D center of Yield Pharma, located in Nanjing Yuhua Economic Development Zone, covers 1, 000 square meters. This center is mainly engaged in the research of pharmaceutical intermediates and APIs as well as all kinds of custom synthesis from milligrams to kilograms. R&D center has standardized labs and a QC room for HPLC and GC to guarantee the quality and purity of our prod